Literature DB >> 12502880

Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.

Mikako Fujita1, Akiko Sakurai, Akiko Yoshida, Maki Miyaura, A Hajime Koyama, Koji Sakai, Akio Adachi.   

Abstract

A hydrophilic region consisting of strikingly clustered charged amino acids is present at the center of human immunodeficiency virus type 1 (HIV-1) Vif. In this study, the role for this central hydrophilic region (E(88)WRKKR(93)) in the virus replication in nonpermissive H9 cells was investigated by extensive deletion and substitution analysis. A total of 31 mutants were constructed. Deletion of the E(88) or W(89) residue alone abolished viral infectivity in H9 cells and impaired virus replication in primary macrophage cultures. Substitution analysis indicated that the hydrophilicity and charge of the central region are insignificant for the function of Vif. Of the 16 substitution mutants, 3 mutants with substitution of E(88) and W(89) with an A residue did not grow in H9 cells. Upon transfection, four mutants (i.e., two mutants with deletion of E(88) or W(89); a mutant with substitution of E(88) and W(89) with A; and a mutant with substitution of E(88), W(89), and R(90) with A) were found to express Vif at a very reduced level relative to that by the wild-type clone. These results have thus demonstrated that amino acid residues 88 and 89 of Vif are critical for the replication of HIV-1 in target cells by enhancing the steady-state expression of Vif. In addition, E(88) and W(89) residues were found to be extremely conserved among the Vif proteins of naturally occurring HIV-1 field isolates as well as those of laboratory HIV-1 strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502880      PMCID: PMC140823          DOI: 10.1128/jvi.77.2.1626-1632.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Human immunodeficiency virus and AIDS: insights from animal lentiviruses.

Authors:  R J Miller; J S Cairns; S Bridges; N Sarver
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype.

Authors:  Mikako Fujita; Akiko Sakurai; Akiko Yoshida; Sora Matsumoto; Maki Miyaura; Akio Adachi
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

3.  Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.

Authors:  Mikako Fujita; Sora Matsumoto; Akiko Sakurai; Naoya Doi; Maki Miyaura; Akiko Yoshida; Akio Adachi
Journal:  Microbes Infect       Date:  2002-10       Impact factor: 2.700

Review 4.  Functional roles of HIV accessory proteins for viral replication (review).

Authors:  R Inubushi; M Tamaki; R Shimano; A H Koyama; H Akari; A Adachi
Journal:  Int J Mol Med       Date:  1998-10       Impact factor: 4.101

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.

Authors:  T Folks; S Benn; A Rabson; T Theodore; M D Hoggan; M Martin; M Lightfoote; K Sell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.

Authors:  M Fujita; A Sakurai; N Doi; M Miyaura; A Yoshida; K Sakai; A Adachi
Journal:  Microbes Infect       Date:  2001-11       Impact factor: 2.700

8.  Cyclophilin A-independent replication of a human immunodeficiency virus type 1 isolate carrying a small portion of the simian immunodeficiency virus SIV(MAC) gag capsid region.

Authors:  M Fujita; A Yoshida; M Miyaura; A Sakurai; H Akari; A H Koyama; A Adachi
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

10.  Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression.

Authors:  J S Lebkowski; S Clancy; M P Calos
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

View more
  11 in total

Review 1.  HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors:  Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal:  Mol Aspects Med       Date:  2010-06-09

2.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

3.  Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages.

Authors:  Mikako Fujita; Masami Otsuka; Masami Miyoshi; Boonruang Khamsri; Masako Nomaguchi; Akio Adachi
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

4.  Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Katsuhiro Io; Kohei Tada; Fumie Iwai; Masayuki Kobayashi; Norimitsu Kadowaki; Reuben S Harris; Akifumi Takaori-Kondo
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

5.  Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

6.  The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.

Authors:  Nzovu K Ulenga; Abdoulaye Dieng Sarr; Donald Hamel; Jean-Louis Sankale; Souleymane Mboup; Phyllis J Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

7.  Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

Authors:  Rebecca A Russell; Vinay K Pathak
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.

Authors:  Ana Clara Ribeiro; Alexandra Maia e Silva; Mariana Santa-Marta; Ana Pombo; José Moniz-Pereira; Joao Goncalves; Isabel Barahona
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

9.  Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?

Authors:  Iris Cadima-Couto; Joao Goncalves
Journal:  Adv Virol       Date:  2010-09-21

10.  Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.

Authors:  Viviana Simon; Veronique Zennou; Deya Murray; Yaoxing Huang; David D Ho; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2005-07-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.